Occudo Quantitative Strategies LP Evolus, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $218,790 - $326,543	21,901 Added 179.58%	34,097 $477,000
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $92,689 - $128,423	12,196 New	12,196 $128,000
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $104,386 - $151,887	14,438 Added 132.08%	25,369 $184,000
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $192,461 - $272,305	-24,643 Reduced 69.27%	10,931 $92,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $74,360 - $102,074	-11,405 Reduced 24.28%	35,574 $267,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $364,557 - $644,551	46,979 New	46,979 $378,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.